Physician profile
Moinuddin Syed
NPI 1750733887
$15,313.95
in general payments reported to CMS, 2019-2025
21 companies · $886 in 2025
The $886 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $99.97 · 2021: $457 · 2022: $457 · 2023: $7,360 · 2024: $5,891 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,312 · Grant: $2,880 · Travel and Lodging: $2,854 · Education: $91.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,312.07 |
| Grant | $2,879.66 |
| Travel and Lodging | $2,854.01 |
| Education | $91.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,727.70 | 2019-2024 | Optis, Perclose Proglide, Supera |
| Medtronic, INC. | $3,270.07 | 2022-2025 | Spiderfx, Symplicity G3, Protege Rx |
| Shockwave Medical, INC | $2,653.40 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $1,044.66 | 2023-2025 | Lutonix Drug Coated Balloon, Crosser Iq, Lifestream |
| W. L. Gore & Associates, INC. | $868.31 | 2021-2025 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $535.55 | 2023-2024 | Cook, Zilver Ptx, Advance |
| Boston Scientific Corporation | $521.72 | 2021-2025 | Watchman Flx, Polaris Ultra, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $499.06 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $255.36 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.46 | 2021-2022 | |
| Cagent Vascular INC | $128.89 | 2024 | Serrantor |
| Cardiva Medical, INC. | $125.02 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Chiesi USA, INC. | $115.49 | 2024 | Kengreal |
| Cardiovascular Systems INC. | $83.33 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $81.25 | 2024 | Arcalyst |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $44.64 | 2023 | Xarelto |
| Amgen INC. | $43.34 | 2019-2025 | Repatha |
| Teleflex LLC | $28.66 | 2023 | Manta |
| Biotronik INC. | $27.45 | 2024 | Orsiro Mission |
| Bayer Healthcare Pharmaceuticals INC. | $18.56 | 2025 | |
| Astellas Pharma US INC | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moinuddin Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.